Dinalbuphine sebacate

DRUG8 trials

Sponsors

Lumosa Therapeutics Co., Ltd., E-DA Hospital, Mackay Memorial Hospital, Tri-Service General Hospital, Li-Jen Hsin

Conditions

AnalgesiaBariatric SurgeryCaesarean SectionCholecystitisHealthLung CancerLung TumorObesity

Phase 1

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

CompletedNCT04256434

Lumosa Therapeutics Co., Ltd.Health

Start: 2020-01-31End: 2020-05-29Updated: 2021-11-19

Phase 2

Naldebain for Pain Control After Bariatric Surgery

E-DA HospitalBariatric Surgery, Obesity, Pain, Chronic +2

Start: 2021-06-24End: 2022-06-30Target: 60Updated: 2021-12-28

Naldebain for Pain Management of Laparoscopic Cholecystectomy

CompletedNCT04808544

E-DA HospitalCholecystitis, Pain, Chronic, Pain, Postoperative +1

Start: 2021-08-30End: 2022-04-18Updated: 2022-04-20

Phase 4

Postoperative Pain Management on Uvulopalatopharyngoplasty Patients

Li-Jen HsinObstructive Sleep Apnea-hypopnea Syndrome, Pain, Acute, Pain, Postoperative

Start: 2023-05-01End: 2024-05-01Target: 78Updated: 2023-04-25

Dinalbuphine Sebacate in Postoperative Pain Control After TKA

Not yet recruitingNCT07140510

Thammasat UniversityOsteo Arthritis of the Knee, Total Knee Anthroplasty

Start: 2025-10-31End: 2026-09-30Target: 100Updated: 2025-08-24

Unknown Phase

Postoperative Pain Management of Caesarean Section

RecruitingNCT05009771

Mackay Memorial HospitalAnalgesia, Caesarean Section, Postoperative Pain

Start: 2022-02-23End: 2026-07-31Target: 100Updated: 2025-05-09

Naldebain® Extended-release Injection After Cesarean Section in Pain Management

Tri-Service General HospitalAnalgesia, Caesarean Section, Post Operative Pain

Start: 2022-07-15End: 2022-12-31Target: 20Updated: 2022-07-06

Postoperative Pain Management on Patients Undergoing Lung Tumor Resection

Not yet recruitingNCT06397807

China Medical University HospitalLung Cancer, Lung Tumor, Postoperative Pain

Start: 2024-05-31End: 2026-05-30Target: 400Updated: 2024-05-03

Related Papers

Efficacy and safety of extended-release dinalbuphine sebacate in a multimodal analgesic regimen following cesarean section: A prospective observational study.

2026-05-01